Drawing for ISVAC

USPTO serial 79052246

ISVAC

Reviewed by CopyMark Law Group

Reg. 3669500Status 404
Filing date
Status date
Registration date
Aug 18, 2009
Examiner
BUTLER, MIDGE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ISVAC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Abigail Rubinstein, Paul Fields, Amy J. Benjamin and Eric A. Prager

Abigail Rubinstein, Paul Fields, Amy J. Benjamin a Darby & Darby P.C.P.O. Box 770, Church Street StationNew York, NY 10008-0770UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations to treat hepatitis C, cancer and other diseases; sanitary preparations for medical purposes; dietetic food substances adapted for medical use; food for babies; plasters, medical dressings; materials for stopping teeth; dental impression compounds; all purpose disinfectants; preparations for destroying vermin; fungicides, herbicides; amino acids for medical purposes; antibiotics; biocides; vaccines; radiological contrast substances for medical purposes; nutritive substances for microorganisms for medical use; radioactive substances for medical purposes; additives to fodder for medical purposes; capsules for medicines sold empty; capsules for pharmaceutical purposes sold empty; candy for medical purposes; confectionery, medicated; medicinal roots; cultures of microorganisms for medical and veterinary use; milk sugar lactose for manufacturing foodstuff, liniments; drugs for medical purposes, namely, rectal suppository for induction of serum interferon in patient, solution for injection for induction of serum interferon in patient, rectal suppository for treatment of hepatitis C and other infectious diseases, solution for injection for treatment of hepatitis C and other infectious diseases, rectal suppository for treatment of cancer, solution for injection for treatment of cancer, rectal suppository to stimulate B-cells in patient, and solution for injection to enhance vaccine response in patient; medicines for veterinary purposes to treat hepatitis C, cancer and other diseases; serotherapeutic medicines and medicines for human purposes for the treatment of hepatitis C; albuminous milk for medical purposes; milk of almonds for pharmaceutical purposes; royal jelly for medical purposes; milk ferments for pharmaceutical purposes; dietetic beverages adapted for medical purposes; malted milk beverages for medical purposes; medical apparatus, namely, injection devices for pharmaceuticals; pills for pharmaceutical purposes, namely, for the treatment of hepatitis C, cancer and other infectious diseases; bacterial preparations for medical and veterinary use; bacteriological preparations for medical and veterinary use; balsamic preparations for medical purposes; albuminous preparations for medical purposes; biological preparations for veterinary purposes; biological preparations for medical purposes; vitamin preparations; diagnostic preparations for medical purposes; medical therapeutic preparations for the bath; preparations for the treatment of hepatitis; preparations for the treatment of AIDS; preparations for the diagnostics of hepatitis; preparations for the diagnostics of AIDS; medicated bath preparations; preparations of trace elements for human and animal use; enzyme preparations for veterinary and medical purposes; chemico-pharmaceutical preparations, namely, chemico-pharmaceutical preparation to induce serum interferon in patient, chemico-pharmaceutical preparation to treat Hepatitis C and other infectious diseases, chemico-pharmaceutical preparation to treat cancer, chemico-pharmaceutical preparation to stimulate B-cells in patient, chemico-pharmaceutical preparation to enhance vaccine response in patient; chemical preparations for veterinary, medical and pharmaceutical purposes; albuminous foodstuffs for medical purposes; dietetic foods adapted for medical purposes; anaesthetics; antiseptics; analgesics; pharmaceutical styptic preparations; parasiticides; febrifuges; depuratives; purgatives; antiparasitic preparations; adjuvants for medical purposes; appetite suppressants for medical purposes; medical preparations for slimming purposes; chemical contraceptives; nervines; digestives aid for pharmaceutical purposes; media for bacteriological cultures; steroids; anti-aging serums; medicinal herbs; tranquillizers; ferments for veterinary, medical and pharmaceutical purposes; herbs teas for medicinal purposes; methyl ethers and methyl esters for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes; rat poison; bacterial poisonsSECTION 71 - CANCELLED—
044Medical services; nursing homes; pharmacy advice; hospitals; aromatherapy services; midwife services; veterinary services; dentistry; medical assistance; rental of sanitation facilities; health care; health spa services, namely, cosmetic body care services; medical services in the nature of a of a psychological consultation; telemedicine services; pharmacists' services to make up prescriptions; nursing, medical; physical therapy; chiropractics; plastic surgery; medical services in the domain of diagnosing and treatment of hepatitis; medical services in the domain of diagnosing and treatment of AIDSSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 17, 2018UNDNUNDELIVERABLE MAIL - NO ACTION TAKEN—
Jul 27, 2018DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Jul 27, 2018DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 24, 2017INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jan 9, 2017XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jan 9, 2017XXCRGENERIC MADRID TRANSACTION CREATED—
Nov 25, 2016INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 25, 2016C71TCANCELLED SECTION 71—
Jan 27, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 2, 2009FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 2, 2009FIMPFINAL DISPOSITION PROCESSED—
Nov 18, 2009FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 18, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 2, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 13, 2009NPUBNOTICE OF PUBLICATION—
Apr 30, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 30, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 29, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 29, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 29, 2009ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Nov 24, 2008GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Nov 24, 2008GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 24, 2008CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 17, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 17, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 17, 2008ALIEASSIGNED TO LIE—
Nov 4, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 13, 2008RFNTREFUSAL PROCESSED BY IB—
Jun 6, 2008ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 6, 2008REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 23, 2008RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 23, 2008RFRRREFUSAL PROCESSED BY MPU—
May 22, 2008RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 21, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 9, 2008DOCKASSIGNED TO EXAMINER—
May 9, 2008NWAPNEW APPLICATION ENTERED—
May 8, 2008REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance